Research Peptides in Southaven, MS

Shipping research peptides to Southaven

Peptides Factory Direct delivers third-party-tested research peptides to Southaven and the surrounding Mississippi area. Orders ship as stable lyophilized vials ready for refrigerated storage and reconstitution in your lab. Whether you are part of a university group, a private research facility, or an independent Southaven researcher, every lot meets the same 99%+ purity target with a Certificate of Analysis on request, identity confirmed by mass spectrometry and purity quantified by HPLC.

Research peptide categories shipped to Southaven

Southaven researchers can order across all seven research categories in the catalog. The table below maps each category to what it is studied for and example compounds.

Research peptides Southaven researchers request most

Below are the research peptides Southaven laboratories most often order. Each summary reflects the published research literature and is provided for laboratory context only, and every compound is research-use-only and is not for human or animal consumption.

Tirzepatide (dual GLP-1/GIP agonist) research

Tirzepatide is a dual agonist that activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. It is one of the most-studied modern metabolic research peptides because it engages two incretin pathways at once.

Research mechanism. Tirzepatide research examines combined GLP-1 and GIP signaling on insulin response, satiety, and energy handling, with the dual-pathway mechanism the central research distinction.

Weight-management research. Studied for body-weight endpoints via dual incretin signaling.

Glucose-metabolism research. Examined for combined GLP-1/GIP metabolic effects.

Comparative incretin studies. Frequently compared with semaglutide.

How it compares. Tirzepatide adds GIP activity on top of GLP-1, which is the defining contrast with single-pathway semaglutide in research.

Research pairings. Studied as a standalone dual-agonist model or compared with semaglutide.

Reference research values. Research references describe a titration model from 2.5 mg up to 15 mg weekly over several weeks. Reference values only.

Full Tirzepatide research profile → · Fat Loss & Weight Management peptides

TB-500 (Thymosin Beta-4 fragment) research

TB-500 is a synthetic peptide corresponding to the active region of Thymosin Beta-4, a naturally occurring protein involved in actin regulation and cell migration. In research it is valued for its reported ability to travel systemically and reach tissue throughout the body rather than acting only at a local site.

Research mechanism. TB-500 research focuses on its binding to G-actin and its role in cell migration, blood-vessel formation, and the recruitment of repair cells to damaged tissue. By promoting cell motility, it is studied as a driver of slower but deeper regeneration than localized repair peptides.

Deep tissue and muscle recovery research. TB-500 is studied across muscle, tendon, and ligament models where whole-body distribution is desirable, and in flexibility and range-of-motion research.

Chronic-injury models. Its systemic profile makes it common in chronic and hard-to-reach injury models where a localized peptide would be impractical.

Stacked regeneration studies. It is the standard research partner for BPC-157 in connective-tissue regeneration protocols.

How it compares. Where BPC-157 is studied as fast and local, TB-500 is studied as slower and systemic. Researchers often choose between them based on whether whole-body distribution or site-specific action is the variable of interest.

Research pairings. TB-500 + BPC-157 is the most-studied healing pair in the literature; the two are reported to address complementary repair pathways. TB-500 is banned by WADA, a relevant note for sports-science researchers.

Reference research values. Published research references commonly cite a loading phase of 5-10 mg per week split across 2-3 administrations for 4-6 weeks, followed by a 2-5 mg per week maintenance figure. These are reference values from the literature and are not instructions for any living subject.

Full TB-500 research profile → · Healing & Recovery peptides

Ovagen (Organ Bioregulator) research

Ovagen is a peptide bioregulator from the Khavinson family, studied for reproductive and organ tissue-support concepts in research models. Peptide bioregulators are investigated for tissue-specific normalization of gene expression and protein synthesis.

Research mechanism. Ovagen research centers on tissue-specific peptide bioregulation - the concept that short peptides can support normal function and protein synthesis in their target organ tissue - within reproductive and organ-support research models.

Reproductive-tissue research. Studied for reproductive and organ tissue-support endpoints in models.

Organ-support research. Examined in bioregulator research focused on tissue normalization concepts.

Longevity bioregulator research. Investigated within the broader Khavinson bioregulator research framework.

How it compares. Ovagen is an organ/reproductive-tissue bioregulator, distinct from the vascular bioregulator Vesugen and the neuro bioregulator Pinealon.

Research pairings. Studied alongside other Khavinson bioregulators (Epithalon, Vesugen, Pinealon) in organ-support research designs.

Reference research values. Research references commonly cite 2-5 mg daily in short-course bioregulator study cycles. Reference values only - not for human or animal use.

Full Ovagen research profile → · Specialty peptides

AOD 9604 (HGH Fragment 176-191) research

AOD 9604 is a modified fragment (residues 176-191) of human growth hormone, representing the region associated with fat metabolism. It is studied because it isolates the lipolytic portion of GH without the growth-signaling or glucose effects of the whole hormone.

Research mechanism. AOD 9604 research focuses on stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis without acting on the IGF-1 axis or blood glucose - the defining research feature.

Lipolysis research. Studied specifically for fat-metabolism endpoints in models.

Metabolic models without glucose effect. Useful where researchers want fat signaling isolated from blood-sugar variables.

Stubborn-fat research. Examined in models of resistant adipose tissue.

How it compares. Unlike GLP-1 peptides that act on appetite, AOD 9604 isolates the fat-metabolism portion of GH and does not affect blood sugar - a distinct research mechanism.

Research pairings. Sometimes studied alongside GH-secretagogues in metabolic research designs.

Reference research values. Research references commonly cite 300-600 mcg daily (often modeled in a fasted window) over 12-16 week study periods. Reference values only.

Full AOD 9604 research profile → · Fat Loss & Weight Management peptides

N-Acetyl Semax Amidate (potent Semax analog) research

N-Acetyl Semax Amidate is a modified version of Semax with acetylation and amidation that the literature associates with greater potency and a longer active window in cognitive-research models.

Research mechanism. Like Semax, it is studied for BDNF and nerve-growth-factor signaling and monoamine modulation, with the modifications extending stability and duration in models.

Advanced cognitive research. Studied for focus, learning, and mental-clarity endpoints with a longer duration.

Neuroprotection research. Examined in neural-stress and recovery models.

BDNF-signaling research. A more stable model compound for neurotrophic studies.

How it compares. It is studied as more potent and longer-lasting than standard Semax, suited to demanding cognitive-research models.

Research pairings. Studied alongside Selank in cognitive-research designs.

Reference research values. Research references commonly cite 300-600 mcg daily across 2-4 week cycles. Reference values only.

Full N-Acetyl Semax Amidate research profile → · Cognitive & Neurological peptides

IGF-1 LR3 (Long R3 Insulin-like Growth Factor 1) research

IGF-1 LR3 is a modified, long-acting analog of insulin-like growth factor 1, with an 83-amino-acid structure and a reduced affinity for binding proteins that gives it an extended active half-life in research models.

Research mechanism. IGF-1 LR3 research focuses on IGF-1-receptor activation driving cell proliferation, nutrient partitioning, and anabolic signaling. Its extended half-life is the defining research feature versus native IGF-1.

Anabolic / growth research. Among the most-studied peptides for cellular growth and protein-synthesis models.

Nutrient-partitioning research. Studied for its reported influence on substrate handling.

Recovery models. Examined for tissue-recovery endpoints in cycled research designs.

How it compares. Where GHRPs and GHRH analogs stimulate endogenous GH, IGF-1 LR3 supplies a downstream IGF signal directly, making it a distinct and more advanced research tool.

Research pairings. IGF-1 LR3 is studied in cycled designs rather than continuous use, sometimes following GH-secretagogue protocols.

Reference research values. Research references commonly cite 40-80 mcg daily in 4-6 week cycled study windows. Reference values only - an advanced research compound.

Full IGF-1 LR3 research profile → · Growth Hormone & Muscle peptides

PT-141 (Bremelanotide) research

PT-141 (Bremelanotide) is a synthetic melanocortin-receptor agonist derived from Melanotan II. It is studied for sexual-function endpoints through a central-nervous-system mechanism rather than a vascular one.

Research mechanism. PT-141 research focuses on activation of melanocortin receptors (notably MC4R) in the central nervous system, which is the distinguishing feature versus vascular mechanisms studied for other compounds.

Libido / sexual-function research. Studied for arousal endpoints in both male and female models via CNS signaling.

Melanocortin-pathway research. A model compound for MC4R signaling studies.

Centrally-mediated research. Used where a central rather than vascular mechanism is the variable.

How it compares. Unlike vascular-pathway compounds, PT-141 acts centrally; unlike Melanotan I/II it is studied primarily for sexual-function rather than tanning endpoints.

Research pairings. Generally studied as a standalone melanocortin agonist.

Reference research values. Research references commonly cite 1-2 mg administered 45-90 minutes before the modeled endpoint, used as-needed rather than daily. Reference values only.

Full PT-141 research profile → · Sexual Health & Tanning peptides

KPV (Lysine-Proline-Valine) research

KPV is the C-terminal tripeptide (lysine-proline-valine) of the alpha-melanocyte-stimulating hormone. In research it is studied because it retains anti-inflammatory activity associated with the parent hormone without the pigmentation effects, making it a clean model compound for inflammation studies.

Research mechanism. KPV research focuses on its reported ability to enter cells and modulate inflammatory transcription pathways (such as NF-kB signaling), reducing pro-inflammatory cytokine output in models of gut and tissue inflammation.

Gut inflammation models. KPV is studied in models relevant to inflammatory bowel research (such as colitis and Crohn-type models) where epithelial inflammation is the variable.

General anti-inflammatory research. It is used as a model peptide for systemic and tissue inflammation studies with minimal off-target signaling.

Immune-modulation research. Its melanocortin lineage makes it relevant to immune-signaling investigations.

How it compares. Unlike BPC-157 and TB-500, which are studied for structural tissue repair, KPV is studied specifically for inflammatory signaling, making it complementary rather than competitive.

Research pairings. In healing research KPV is sometimes studied alongside BPC-157 for combined repair-and-inflammation models.

Reference research values. Research references commonly cite 500-1,000 mcg daily across a 4-12 week study window. Reference values only - not dosing for any subject.

Full KPV research profile → · Healing & Recovery peptides

Vesugen (KED Vascular Bioregulator) research

Vesugen is a short vascular peptide bioregulator (a tripeptide, KED) from the Khavinson family, studied for endothelial and vessel-wall support signaling in research models. It is the vascular-tissue member of the short-peptide bioregulator group.

Research mechanism. Vesugen research focuses on vascular and endothelial tissue bioregulation - the concept that a tissue-specific short peptide can support normal endothelial function and vessel-wall protein synthesis - within cardiovascular-tissue research models.

Vascular / endothelial research. Studied for endothelial-function and vessel-support endpoints in models.

Cardiovascular-tissue research. Examined in bioregulator research focused on vascular tissue normalization.

Longevity bioregulator research. Investigated within the broader Khavinson bioregulator framework.

How it compares. Vesugen is the vascular/endothelial bioregulator, distinct from the organ bioregulator Ovagen and the neuro bioregulator Pinealon.

Research pairings. Studied alongside other Khavinson bioregulators (Epithalon, Ovagen, Pinealon) in tissue-support research designs.

Reference research values. Research references commonly cite 2-5 mg daily in short-course bioregulator study cycles. Reference values only - not for human or animal use.

Full Vesugen research profile → · Specialty peptides

Melanotan II (MT-II) research

Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone, a non-selective melanocortin agonist. It is studied for melanogenesis (pigmentation) and broader melanocortin endpoints in research models.

Research mechanism. Melanotan II activates multiple melanocortin receptors, driving melanin production in research models and engaging MC4R pathways relevant to appetite and libido endpoints.

Pigmentation research. Studied for melanogenesis and tanning endpoints in models.

Melanocortin-pathway research. A broad melanocortin agonist for receptor studies.

Appetite/libido signaling research. Examined for MC4R-mediated endpoints.

How it compares. Melanotan II is a non-selective agonist studied for pigmentation and broad melanocortin endpoints; Melanotan I (afamelanotide) is more selective; PT-141 is studied for sexual function.

Research pairings. Generally studied as a standalone melanocortin agonist.

Reference research values. Research references commonly cite 0.5-1 mg two to three times weekly. Reference values only.

Full Melanotan II research profile → · Sexual Health & Tanning peptides

GHRP-2 (Growth Hormone Releasing Peptide-2) research

GHRP-2 is a synthetic hexapeptide growth-hormone secretagogue, studied as a middle ground between GHRP-6 (strong appetite signaling) and Ipamorelin (selective and clean).

Research mechanism. GHRP-2 activates the GH-secretagogue receptor for GH release, with a reportedly smaller appetite response than GHRP-6 and somewhat more than Ipamorelin in research models.

GH-release research. A potent GHRP for growth-hormone-pulse studies.

Body-composition models. Studied for downstream metabolic endpoints.

GHRH synergy research. Paired with CJC-1295 in stacking studies.

How it compares. GHRP-2 is studied as a balance between GHRP-6 potency/appetite and Ipamorelin selectivity.

Research pairings. GHRP-2 + CJC-1295 is a common research pairing; prolactin is monitored in models.

Reference research values. Research references commonly cite 100-300 mcg two to three times daily. Reference values only.

Full GHRP-2 research profile → · Growth Hormone & Muscle peptides

Ipamorelin (selective GHRP) research

Ipamorelin is a pentapeptide and a selective growth-hormone secretagogue (a GHRP). In research it is valued for being one of the most selective GHRPs, reported to stimulate GH release with minimal effect on cortisol or prolactin compared with older GHRPs.

Research mechanism. Ipamorelin acts on the ghrelin/GH-secretagogue receptor to trigger growth-hormone release. Its selectivity is the central research interest, since it isolates the GH-release variable without confounding hormonal signals.

Selective GH-release research. Used as a clean GHRP in studies where minimizing cortisol/prolactin interference matters.

GHRH synergy models. Most often studied with CJC-1295 to amplify GH pulses.

Body-composition and recovery research. Downstream metabolic and recovery endpoints are studied in models.

How it compares. Compared with GHRP-6 and GHRP-2, Ipamorelin is studied as the most selective option with the least off-target hormonal signaling; compared with Hexarelin it is gentler but less potent.

Research pairings. Ipamorelin + CJC-1295 (no DAC) is the standard research stack for amplified, relatively clean GH release.

Reference research values. Research references commonly cite 200-300 mcg before rest periods on a 5-7 day schedule. Reference values only.

Full Ipamorelin research profile → · Growth Hormone & Muscle peptides

Tesamorelin (GHRH analog) research

Tesamorelin is a stabilized analog of growth-hormone-releasing hormone studied for its reported effect on visceral adipose tissue - the fat surrounding internal organs - in metabolic research models.

Research mechanism. Tesamorelin stimulates endogenous GH release like other GHRH analogs, with research focused specifically on visceral-fat endpoints rather than subcutaneous fat.

Visceral-fat research. Studied specifically for visceral adipose tissue endpoints.

Metabolic-health models. Examined for broader metabolic-syndrome research variables.

GHRH-axis research. Used as a GHRH analog in GH-release studies.

How it compares. Tesamorelin is studied for visceral fat specifically, distinguishing it from AOD 9604 (general lipolysis) and the GLP-1 peptides (appetite).

Research pairings. Studied as a standalone GHRH analog in metabolic research.

Reference research values. Research references commonly cite 1-2 mg daily. Reference values only.

Full Tesamorelin research profile → · Fat Loss & Weight Management peptides

Hexarelin (potent GHRP) research

Hexarelin is a synthetic hexapeptide and one of the most potent growth-hormone-releasing peptides studied in research, with reported activity beyond GH release including cardiovascular-tissue signaling.

Research mechanism. Hexarelin strongly activates the GH-secretagogue receptor. Research notes desensitization with continuous exposure and increases in prolactin and cortisol, so cycled study designs are common.

Potent GH-release research. Studied where maximal GH-pulse stimulation is the variable.

Cardiac-tissue research. Examined for reported GH-independent cardiovascular signaling.

Cycled GHRP designs. Used in research that models receptor desensitization.

How it compares. Hexarelin is the most potent GHRP studied here but with the most off-target signaling and desensitization, contrasting with the gentler Ipamorelin.

Research pairings. Hexarelin is studied in cycled designs and monitored for prolactin/cortisol; it is rarely combined continuously with other GHRPs.

Reference research values. Research references commonly cite 100-200 mcg two to three times daily across 4-8 week cycles. Reference values only.

Full Hexarelin research profile → · Growth Hormone & Muscle peptides

Research applications studied in Southaven

• Weight-management research (Tirzepatide). Studied for body-weight endpoints via dual incretin signaling.
• Deep tissue and muscle recovery research (TB-500). TB-500 is studied across muscle, tendon, and ligament models where whole-body distribution is desirable, and in flexibility and range-of-motion research.
• Reproductive-tissue research (Ovagen). Studied for reproductive and organ tissue-support endpoints in models.
• Lipolysis research (AOD 9604). Studied specifically for fat-metabolism endpoints in models.
• Advanced cognitive research (N-Acetyl Semax Amidate). Studied for focus, learning, and mental-clarity endpoints with a longer duration.

How Southaven researchers order and store material

Place a one-time or recurring research order through the Peptides Factory Direct portal; checkout requires confirming you are 21 or older and buying for laboratory research only. Material ships to Southaven as a stable lyophilized powder; refrigerate on arrival, reconstitute with bacteriostatic water when ready, and keep refrigerated through the research window. Products are research-use-only and not for human or animal consumption, and Southaven researchers are responsible for compliance with applicable law. Open the order portal.

Why Southaven researchers choose Peptides Factory Direct

Research buyers in Southaven choose Peptides Factory Direct for one reason: verifiable quality. Every Southaven shipment carries a 99%+ purity target, a Certificate of Analysis on request, full lot tracking, and reference documentation for each compound. Fast domestic dispatch gets stable vials to Southaven labs without delay, and pricing and standards match every other US research address.

Nearby Mississippi research areas we ship to

Frequently asked questions

All Mississippi cities · All states · Research guides

External references: Mississippi (Wikipedia) · U.S. Census Bureau